{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T16:33:52Z","timestamp":1749227632796},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.prp.2015.11.021","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T22:55:40Z","timestamp":1456959340000},"page":"509-516","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The expression of osteopontin and vascular endothelial growth factor in correlation with angiogenesis in monoclonal gammopathy of undetermined significance and multiple myeloma"],"prefix":"10.1016","volume":"212","author":[{"given":"Emina","family":"Babarovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toni","family":"Valkovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Budisavljevi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Balen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanja","family":"\u0160tifter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antica","family":"Duleti\u0107-Na\u010dinovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ksenija","family":"Lu\u010din","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nives","family":"Jonji\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2015.11.021_bib0195","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2015.11.021_bib0200","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","article-title":"A monoclonal gammopathy precedes multiple myeloma in most patients","volume":"113","author":"Weiss","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.prp.2015.11.021_bib0205","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","article-title":"Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study","volume":"375","author":"Dispenzieri","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2015.11.021_bib0210","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2015.11.021_bib0215","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1365-2141.2007.06873.x","article-title":"Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression","volume":"139","author":"Kyle","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.prp.2015.11.021_bib0220","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1586\/erm.10.31","article-title":"Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis","volume":"10","author":"Balakumaran","year":"2010","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.prp.2015.11.021_bib0225","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/ajh.21374","article-title":"Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo","volume":"84","author":"Edwards","year":"2009","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.prp.2015.11.021_bib0230","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1038\/sj.onc.1209456","article-title":"Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma","volume":"25","author":"Ribatti","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2015.11.021_bib0235","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10555-007-9104-9","article-title":"Osteopontin: regulation in tumor metastasis","volume":"27","author":"Wai","year":"2008","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.prp.2015.11.021_bib0240","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1022550721404","article-title":"Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a Ras-activated enhancer in the human OPN promoter","volume":"20","author":"Denhardt","year":"2003","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.prp.2015.11.021_bib0245","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1158\/1078-0432.CCR-1405-2","article-title":"Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies","volume":"10","author":"Coppola","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2015.11.021_bib0250","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/mc.20105","article-title":"Osteopontin induces multiple changes in gene expression that reflect the six hallmarks of cancer in model of breast cancer progression","volume":"43","author":"Cook","year":"2005","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.prp.2015.11.021_bib0255","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/sj.bjc.6605834","article-title":"Osteopontin is a marker for cancer aggressiveness and patient survival","volume":"103","author":"Weber","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2015.11.021_bib0260","first-page":"174","article-title":"Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma","volume":"89","author":"Standal","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.prp.2015.11.021_bib0265","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1365-2141.2003.04589.x","article-title":"Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implications","volume":"123","author":"Saeki","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.prp.2015.11.021_bib0270","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2141.2005.05886.x","article-title":"The involvement of osteopontin and its receptors in multiple myeloma cell survival, migration and invasion in the murine 5T33MM model","volume":"132","author":"Caers","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.prp.2015.11.021_bib0275","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/hon.803","article-title":"Osteopontin dysregulation and lytic bone lesions in multiple myeloma","volume":"25","author":"Robbiani","year":"2007","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.prp.2015.11.021_bib0280","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/sj.leu.2403976","article-title":"Human myeloma cells express the bone regulating gene Runx2\/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients","volume":"19","author":"Colla","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.prp.2015.11.021_bib0285","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1182\/blood.V98.2.428","article-title":"Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration","volume":"98","author":"Podar","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.prp.2015.11.021_bib0290","first-page":"176","article-title":"A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma","volume":"88","author":"Vacca","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.prp.2015.11.021_bib0295","first-page":"293","article-title":"Stimulation of endothelial cell migration by vascular permeability factor\/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin","volume":"149","author":"Senger","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2015.11.021_bib0300","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1158\/1078-0432.CCR-06-2258","article-title":"Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin","volume":"13","author":"Tanaka","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2015.11.021_bib0305","first-page":"2210","article-title":"Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis","volume":"8","author":"Rajkumar","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2015.11.021_bib0310","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.leu.2404067","article-title":"Bone marrow angiogenesis in multiple myeloma","volume":"20","author":"Vacca","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.prp.2015.11.021_bib0315","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","author":"International Myeloma Working Group","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.prp.2015.11.021_bib0320","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2015.11.021_bib0325","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1309\/AJCPT5Y2JRIUUCUB","article-title":"Assessment of bone marrow fibrosis and angiogenesis in monitoring patients with multiple myeloma","volume":"137","author":"Babarovi\u0107","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2015.11.021_bib0330","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood-2003-11-3811","article-title":"Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression","volume":"104","author":"Kumar","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.prp.2015.11.021_bib0335","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-0609.2004.00314.x","article-title":"Prognostic significance of vascular endothelial growth factor immunoexpression in the context of adverse standard prognostic factors in multiple myeloma","volume":"73","author":"Ribas","year":"2004","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.prp.2015.11.021_bib0340","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12032-008-9066-y","article-title":"Expression of VEGF and microvessel density in patients with multiple myeloma: clinical and prognostic significance","volume":"25","author":"Markovi\u0107","year":"2008","journal-title":"Med. Oncol."},{"key":"10.1016\/j.prp.2015.11.021_bib0345","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jtcvs.2009.08.016","article-title":"Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneity","volume":"139","author":"Blasberg","year":"2010","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.prp.2015.11.021_bib0350","first-page":"3111","article-title":"Prognostic value of bone marrow angiogenesis in multiple myeloma","volume":"6","author":"Rajkumar","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2015.11.021_bib0355","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ajh.20639","volume":"81","author":"Bhatti","year":"2006","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.prp.2015.11.021_bib0360","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/S0002-9440(10)64325-8","article-title":"Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis","volume":"162","author":"Giavazzi","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2015.11.021_bib0365","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1164\/ajrccm.160.4.9807094","article-title":"Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma","volume":"160","author":"Shijubo","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.prp.2015.11.021_bib0370","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1182\/blood-2003-08-2946","article-title":"Angiogenic switch during 5T2MM murine myeloma tumorigenesis: role of CD45 heterogeneity","volume":"103","author":"Asosingh","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.prp.2015.11.021_bib0375","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1182\/blood-2009-02-207209","article-title":"Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034)","volume":"113","author":"Prince","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.prp.2015.11.021_bib0380","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.canlet.2010.08.011","article-title":"A bispecific antibody effectively inhibits tumor growth and metastasis by simultaneous blocking vascular endothelial growth factor A and osteopontin","volume":"299","author":"Kou","year":"2010","journal-title":"Cancer Lett."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033815300431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033815300431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T18:52:14Z","timestamp":1718391134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033815300431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0344033815300431"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2015.11.021","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The expression of osteopontin and vascular endothelial growth factor in correlation with angiogenesis in monoclonal gammopathy of undetermined significance and multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2015.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}